You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 56, 21 April 2006
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 55, 17 February 2006), as amended, are a true and accurate record of that meeting.
CMEC endorsed the following coded indication as being suitable for use in for Listed medicines:
"May help reduce the frequency of recurrent cystitis in normal healthy women.
If symptoms of cystitis develop, consult your healthcare practitioner."
|Complementary Medicines Evaluation Committee meeting 56 (pdf)||96KB|